Clinical and pharmacological phase I evaluation of Exherin™ (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours
Titel:
Clinical and pharmacological phase I evaluation of Exherin™ (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours
Auteur:
Perotti, A. Sessa, C. Mancuso, A. Noberasco, C. Cresta, S. Locatelli, A. Carcangiu, M.L. Passera, K. Braghetti, A. Scaramuzza, D. Zanaboni, F. Fasolo, A. Capri, G. Miani, M. Peters, W.P. Gianni, L.